Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Consolidation with Nivolumab and Brentuximab Vedotin after Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-136384

Published: 2020

Journal Articles

Coronary Heart Disease Risk in Blood or Marrow Transplant Survivors

Radhika Gangaraju, MD, Yanjun Chen, MS, Lindsey Hageman, MPH, Jessica Wu, MPH, Liton F. Francisco, BS, Michelle Kung, MA, Daniel J. Weisdorf, MD, Stephen J. Forman, MD, Mukta Arora, MD, Saro H. Armenian, DO, MPH, Smita Bhatia, MDMPH

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-137731

Published: 2020

Journal Articles

Severe/Life-Threatening/Fatal Chronic Health Conditions (CHCs) after Allogeneic Blood or Marrow Transplantation (BMT) in Childhood - a Report from the BMT Survivor Study (BMTSS)

Anna Sallfors Holmqvist, MD PhD, Yanjun Chen, MS, Jessica Wu, MPH, Lindsey Hageman, MPH, Kevin D. Battles, BS, Liton F. Francisco, BS, Michelle Kung, MA, Frederick Goldman, MDMS, Joseph Rosenthal, MD MS, Stephen J. Forman, MD, Daniel J. Weisdorf, MD, Mukta Arora, MD, Saro H. Armenian, DO, MPH, Smita Bhatia, MDMPH

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-133895

Published: 2020

Journal Articles

Longitudinal Trajectory of Frailty in Blood or Marrow Transplant (BMT) Survivors - a BMT Survivor Study (BMTSS)

Mukta Arora, MD, Yanjun Chen, MS, Jessica Wu, MPH, Lindsey Hageman, MPH, Emily Ness, MPH, Michelle Kung, MA, Liton F. Francisco, BS, Alysia Bosworth, BA, Daniel J. Weisdorf, MD, Stephen J Forman, MD, Wendy Landier, PhD CRNP, Merve - Pamukçuoğlu, MD, Saro H. Armenian, DO, MPH, Lennie Wong, PhD, Smita Bhatia, MDMPH

Blood (2019) 134 (Supplement_1): 699.

https://doi.org/10.1182/blood-2019-123344

Published: 2019

Journal Articles

Burden of Long-Term Morbidity Borne By Survivors of Acute Myeloid Leukemia (AML) Treated with Blood or Marrow Transplantation (BMT) - a Report from the BMT Survivor Study (BMTSS)

Saro H. Armenian, DO, MPH, Yanjun Chen, MS, Lindsey Hageman, MPH, Jessica Wu, MPH, Liton F. Francisco, BS, Michelle Kung, MA, Emily Ness, MPH, Mariel Parman, MPH, Wendy Landier, PhD CRNP, Alysia Bosworth, BA, Lennie Wong, PhD, Daniel J. Weisdorf, MD, Stephen J Forman, MD, Mukta Arora, MD, Smita Bhatia, MDMPH

Blood (2019) 134 (Supplement_1): 707.

https://doi.org/10.1182/blood-2019-126248

Published: 2019

Journal Articles

Diagnostic Predictive Model for Diagnosis of Heart Failure after Hematopoietic Cell Transplantation (HCT): Comparison of Traditional Statistical with Machine Learning Modeling

Benjamin Djulbegovic, MD, Jennifer Berano Teh, Lennie Wong, PhD, Iztok Hozo, PhD, Saro H. Armenian, DO, MPH

Blood (2019) 134 (Supplement_1): 5799.

https://doi.org/10.1182/blood-2019-130764

Published: 2019

Journal Articles

Stroke Risk in Blood or Marrow Transplant (BMT) Survivors - a Report from the BMT Survivor Study (BMTSS)

Radhika Gangaraju, MD, Yanjun Chen, MS, Lindsey Hageman, MPH, Jessica Wu, MPH, Wendy Landier, PhD CRNP, Liton F. Francisco, BS, Andrew McDonald, Donna Murdaugh, PhD, Michelle Kung, MA, Emily Ness, MPH, Daniel J. Weisdorf, MD, Stephen J Forman, MD, Lennie Wong, PhD, Mukta Arora, MD, Saro H. Armenian, DO, MPH, Smita Bhatia, MDMPH

Blood (2019) 134 (Supplement_1): 3298.

https://doi.org/10.1182/blood-2019-124564

Published: 2019

Journal Articles

Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial

Blood (2019) 134 (Supplement_1): 2843.

https://doi.org/10.1182/blood-2019-126661

Published: 2019

Journal Articles

Preliminary Results from a Phase I Trial of Pembrolizumab Plus Vorinostat in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Hodgkin Lymphoma

Alex F. Herrera, MD, Lu Chen, PhD, Leslie L. Popplewell, MD FRCPA, Lihua E Budde, MD PhD, Matthew Mei, MD, Saro H. Armenian, DO, MPH, Justin Darrah, MD, Liana Nikolaenko, MD, Robert W. Chen, MD, Lacolle Peters, Neena Kennedy, Steven Rosen, MD, Stephen J Forman, MD, Larry W Kwak, MD PhD

Blood (2019) 134 (Supplement_1): 759.

https://doi.org/10.1182/blood-2019-123163

Published: 2019

Journal Articles

Incidence and Risk Factors of De Novo Skin Cancer in a Contemporary Cohort of Hematopoietic Cell Transplantation Survivors

Jennifer Berano Teh, Farah Abdulla, MD, Kelly Peng, Liezl Atencio, Alicia Gonzales, Meagan Echevarria, Alex Iukuridze, Alan Geller, Heeyoung Kim, Lennie Wong, PhD, Stephen J Forman, MD, Ryotaro Nakamura, MD, Badri Modi, MD, Saro H. Armenian, DO, MPH

Blood (2019) 134 (Supplement_1): 2011.

https://doi.org/10.1182/blood-2019-124993

Published: 2019

Journal Articles

Venous Thromboembolism in Blood or Marrow Transplant (BMT) Survivors: A Report from BMT Survivor Study (BMTSS)

Radhika Gangaraju, MD, Yanjun Chen, MS, Lindsey Hageman, MPH, Jessica Wu, MPH, Liton F. Francisco, BS, Michelle Kung, MA, Emily Ness, MPH, Mariel Parman, MPH, Daniel J. Weisdorf, MD, Stephen J Forman, Mukta Arora, MD, Saro H. Armenian, DO, MPH, Smita Bhatia, MD MPH

Blood (2018) 132 (Supplement 1): 823.

https://doi.org/10.1182/blood-2018-99-111179

Published: 2018

Journal Articles

Muscle Depletion Is an Important and Clinically Relevant Predictor of Outcomes after Autologous Hematopoietic Cell Transplantation

Alex Iukuridze, Meisi Xiao, MPH, Lee Brandyn, Jennifer Berano Teh, Kristen Mascarenhas, Sandra Xu, Nicholas Rosen, Jeannine S McCune, PharmD, Jasmine M. Zain, MD, Robert W. Chen, MD, Leslie Popplewell, MD, Jessica Scott, PhD, Thomas Slavin, MD, Lee Jones, PhD, Stephen J Forman, Ryotaro Nakamura, MD, F. Lennie Wong, PhD, Saro H. Armenian, DO,MPH

Blood (2018) 132 (Supplement 1): 620.

https://doi.org/10.1182/blood-2018-99-113689

Published: 2018

Journal Articles

Chronic Severe Pain and Use of Prescription Pain Medications in Older Survivors of Hematologic Malignancies (HM) Several Years after Treatment with Blood or Marrow Transplantation (BMT): A Report from BMTSS

Naveed Farrukh, Lindsey Hageman, MPH, Yanjun Chen, MS, Jessica Wu, MPH, Emily Ness, MPH, Liton F. Francisco, BS, Mariel Parman, MPH, Wendy Landier, PhD CRNP, Mukta Arora, MD, Saro H. Armenian, DO, MPH, Grant R Williams, Smita Bhatia, MD MPH

Blood (2018) 132 (Supplement 1): 715.

https://doi.org/10.1182/blood-2018-99-111500

Published: 2018

Journal Articles

Conditional Survival and Mortality Risks after Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Patients Who Survived Varying Length of Time after Allohct

F. Lennie Wong, PhD, Meisi Xiao, MPH, Jennifer Berano Teh, Liezl Atencio, Alicia Gonzales, Amy Hinton, David Iukuridze, Stephen J Forman, Ryotaro Nakamura, MD, Saro H. Armenian, DO,MPH

Blood (2018) 132 (Supplement 1): 368.

https://doi.org/10.1182/blood-2018-99-112646

Published: 2018

Journal Articles

Burden of Morbidity Borne By Survivors of Multiple Myeloma (MM) Treated with Autologous Blood or Marrow Transplant (BMT) — Results of the BMT Survivor Study (BMTSS)

Mukta Arora, MD, Yanjun Chen, MS, Lindsey Hageman, MPH, Jessica Wu, MPH, Liton F. Francisco, BS, Michelle Kung, MA, Emily Ness, MPH, Mariel Parman, MPH, Daniel J. Weisdorf, MD, Stephen J Forman, Saro H. Armenian, DO, MPH, Smita Bhatia, MD MPH

Blood (2018) 132 (Supplement 1): 2127.

https://doi.org/10.1182/blood-2018-99-112702

Published: 2018

Journal Articles

Reduction in Late Mortality after Autologous Blood or Marrow Transplantation (autoBMT) in Childhood - a Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2)

Anna Sallfors Holmqvist, MD PhD, Yanjun Chen, MS, Jessica Wu, BA, Lindsey Hageman, MPH, Liton F. Francisco, BS, Mariel Parman, MPH, Michelle Kung, MA, Emily Ness, MPH, Kevin D. Battles, BS, Jeanette Falck Winther, MD DMSc, Joseph Rosenthal, MD MS, Ravi Bhatia, MD, Donna Salzman, MD, Stephen J. Forman, MD FACP, Daniel J. Weisdorf, MD, Saro H. Armenian, DO,MPH, Mukta Arora, MD, Smita Bhatia, MDMPH

Blood (2017) 130 (Supplement 1): 337.

https://doi.org/10.1182/blood.V130.Suppl_1.337.337

Published: 2017

Journal Articles

Risk of Subsequent Malignant Neoplasms in Survivors of Adolescent and Young Adult (AYA) Lymphoma and Leukemia

Chun Chao, PhD, Lanfang Xu, Kim Cannavale, F Lennie Wong, Po-Yin Huang, Robert Cooper, Smita Bhatia, MDMPH, Saro H. Armenian, DO,MPH

Blood (2017) 130 (Supplement 1): 608.

https://doi.org/10.1182/blood.V130.Suppl_1.608.608

Published: 2017

Journal Articles

Long-Term Morbidity Associated with Chronic Graft Vs. Host Disease (cGvHD) - a Blood or Marrow Transplant Survivor Study (BMTSS)

Mukta Arora, MD, Yanjun Chen, Jessica Wu, BA, Lindsey Hageman, MPH, Liton F. Francisco, BS, Emily Ness, MPH, Mariel Parman, MPH, Michelle Kung, MA, Alysia Bosworth, BA, Manju Nayar, Ravi Bhatia, MD, Stephen J. Forman, MD FACP, Daniel J. Weisdorf, MD, Saro H. Armenian, DO,MPH, Smita Bhatia, MDMPH

Blood (2017) 130 (Supplement 1): 336.

https://doi.org/10.1182/blood.V130.Suppl_1.336.336

Published: 2017

Journal Articles

High-Intensity Healthcare Utilization and Costs Among Older 10+y Survivors of Allogeneic Blood or Marrow Transplantation (BMT): A Report from the BMT Survivor Study-2 (BMTSS-2)

Eric Kim, Smita Bhatia, MDMPH, Lindsey Hageman, MPH, Jessica Wu, BA, Liton F. Francisco, BS, Emily Ness, MPH, Mariel Parman, MPH, Michelle Kung, MA, Alysia Bosworth, BA, Stephen J. Forman, MD FACP, Daniel J. Weisdorf, MD, Mukta Arora, MD, Saro H. Armenian, DO,MPH, Kelly Kenzik, MS, PhD

Blood (2017) 130 (Supplement 1): 4686.

https://doi.org/10.1182/blood.V130.Suppl_1.4686.4686

Published: 2017

Journal Articles

Phase II Study of Brentuximab Vedotin Plus Ibrutinib for Patients with Relapsed/Refractory Hodgkin Lymphoma

Robert W. Chen, MD, Joycelynne M. Palmer, PhD, Alex Francisco Herrera, MD, Saro H. Armenian, DO,MPH, Matthew Mei, MD, Leslie Popplewell**, MD, Abbey Fueger, Imran Qasim, Tracy Stiller, Steven T. Rosen, MD, Stephen J. Forman, MD FACP, Larry W Kwak, MDPhD

Blood (2017) 130 (Supplement 1): 738.

https://doi.org/10.1182/blood.V130.Suppl_1.738.738

Published: 2017

NARROW

Consolidation with Nivolumab and Brentuximab Vedotin after Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma

Coronary Heart Disease Risk in Blood or Marrow Transplant Survivors

Severe/Life-Threatening/Fatal Chronic Health Conditions (CHCs) after Allogeneic Blood or Marrow Transplantation (BMT) in Childhood - a Report from the BMT Survivor Study (BMTSS)

Longitudinal Trajectory of Frailty in Blood or Marrow Transplant (BMT) Survivors - a BMT Survivor Study (BMTSS)

Burden of Long-Term Morbidity Borne By Survivors of Acute Myeloid Leukemia (AML) Treated with Blood or Marrow Transplantation (BMT) - a Report from the BMT Survivor Study (BMTSS)

Diagnostic Predictive Model for Diagnosis of Heart Failure after Hematopoietic Cell Transplantation (HCT): Comparison of Traditional Statistical with Machine Learning Modeling

Stroke Risk in Blood or Marrow Transplant (BMT) Survivors - a Report from the BMT Survivor Study (BMTSS)

Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial

Preliminary Results from a Phase I Trial of Pembrolizumab Plus Vorinostat in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Hodgkin Lymphoma

Incidence and Risk Factors of De Novo Skin Cancer in a Contemporary Cohort of Hematopoietic Cell Transplantation Survivors

Venous Thromboembolism in Blood or Marrow Transplant (BMT) Survivors: A Report from BMT Survivor Study (BMTSS)

Muscle Depletion Is an Important and Clinically Relevant Predictor of Outcomes after Autologous Hematopoietic Cell Transplantation

Chronic Severe Pain and Use of Prescription Pain Medications in Older Survivors of Hematologic Malignancies (HM) Several Years after Treatment with Blood or Marrow Transplantation (BMT): A Report from BMTSS

Conditional Survival and Mortality Risks after Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Patients Who Survived Varying Length of Time after Allohct

Burden of Morbidity Borne By Survivors of Multiple Myeloma (MM) Treated with Autologous Blood or Marrow Transplant (BMT) — Results of the BMT Survivor Study (BMTSS)

Reduction in Late Mortality after Autologous Blood or Marrow Transplantation (autoBMT) in Childhood - a Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2)

Risk of Subsequent Malignant Neoplasms in Survivors of Adolescent and Young Adult (AYA) Lymphoma and Leukemia

Long-Term Morbidity Associated with Chronic Graft Vs. Host Disease (cGvHD) - a Blood or Marrow Transplant Survivor Study (BMTSS)

High-Intensity Healthcare Utilization and Costs Among Older 10+y Survivors of Allogeneic Blood or Marrow Transplantation (BMT): A Report from the BMT Survivor Study-2 (BMTSS-2)

Phase II Study of Brentuximab Vedotin Plus Ibrutinib for Patients with Relapsed/Refractory Hodgkin Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only